Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schottenfeld

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Drug and Alcohol Dependence|June 10, 2005
The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?Lynn E Sullivan, Marek Chawarski, Patrick G O'Connor, et al.
Journal of Substance Abuse Treatment|May 22, 2007
Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependenceMarek C Chawarski, David A Fiellin, Patrick G O'Connor, et al.
The Journal of Clinical Psychiatry|July 18, 2009
Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patientsDeclan T Barry, Mark Beitel, Brian Garnet, et al.
Journal of Psychiatric Research|March 12, 2014
Profiles of psychiatric symptoms among amphetamine type stimulant and ketamine using inpatients in Wuhan, ChinaYao Zhang, Zaifeng Xu, Sheng Zhang, et al.
Journal of Consulting and Clinical Psychology|January 6, 1999
When is less treatment better? The role of social anxiety in matching methadone patients to psychosocial treatmentsS K Avants, A Margolin, T R Kosten, et al.
Biological Psychiatry|June 23, 2000
Thrice-weekly versus daily buprenorphine maintenanceR S Schottenfeld, J Pakes, P O'Connor, et al.
The American Journal of Drug and Alcohol Abuse|January 1, 1989
Limitation and potential hazards of MAOI's for the treatment of depressive symptoms in abstinent alcoholicsR S Schottenfeld, S S O'Malley, L Smith, et al.
Journal of Substance Abuse Treatment|November 29, 2005
Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy, and symptomsMarek C Chawarski, David E Moody, Juliana Pakes, et al.
Drug and Alcohol Dependence|May 4, 2015
Buprenorphine/naloxone treatment practices in Malaysia: Results of national surveys of physicians and patientsB Vicknasingam, M N M Dazali, D Singh, et al.
Journal of General Internal Medicine|September 1, 1992
Ambulatory opiate detoxification and primary care: a role for the primary care physicianP G O'Connor, M E Waugh, R S Schottenfeld, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Drug and Alcohol Dependence|June 10, 2005
The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?Lynn E Sullivan, Marek Chawarski, Patrick G O'Connor, et al.
Journal of Substance Abuse Treatment|May 22, 2007
Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependenceMarek C Chawarski, David A Fiellin, Patrick G O'Connor, et al.
The Journal of Clinical Psychiatry|July 18, 2009
Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patientsDeclan T Barry, Mark Beitel, Brian Garnet, et al.
Journal of Psychiatric Research|March 12, 2014
Profiles of psychiatric symptoms among amphetamine type stimulant and ketamine using inpatients in Wuhan, ChinaYao Zhang, Zaifeng Xu, Sheng Zhang, et al.
Journal of Consulting and Clinical Psychology|January 6, 1999
When is less treatment better? The role of social anxiety in matching methadone patients to psychosocial treatmentsS K Avants, A Margolin, T R Kosten, et al.
Biological Psychiatry|June 23, 2000
Thrice-weekly versus daily buprenorphine maintenanceR S Schottenfeld, J Pakes, P O'Connor, et al.
The American Journal of Drug and Alcohol Abuse|January 1, 1989
Limitation and potential hazards of MAOI's for the treatment of depressive symptoms in abstinent alcoholicsR S Schottenfeld, S S O'Malley, L Smith, et al.
Journal of Substance Abuse Treatment|November 29, 2005
Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy, and symptomsMarek C Chawarski, David E Moody, Juliana Pakes, et al.
Drug and Alcohol Dependence|May 4, 2015
Buprenorphine/naloxone treatment practices in Malaysia: Results of national surveys of physicians and patientsB Vicknasingam, M N M Dazali, D Singh, et al.
Journal of General Internal Medicine|September 1, 1992
Ambulatory opiate detoxification and primary care: a role for the primary care physicianP G O'Connor, M E Waugh, R S Schottenfeld, et al.
Pageof 12